DK0821955T3 - Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse - Google Patents

Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse

Info

Publication number
DK0821955T3
DK0821955T3 DK97305585T DK97305585T DK0821955T3 DK 0821955 T3 DK0821955 T3 DK 0821955T3 DK 97305585 T DK97305585 T DK 97305585T DK 97305585 T DK97305585 T DK 97305585T DK 0821955 T3 DK0821955 T3 DK 0821955T3
Authority
DK
Denmark
Prior art keywords
heoxyloxy
xanomelin
thiadiazol
methylpyridine
tetrahydro
Prior art date
Application number
DK97305585T
Other languages
English (en)
Inventor
Franklin Porter Bymaster
Harlan Edgar Shannon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0821955T3 publication Critical patent/DK0821955T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Press Drives And Press Lines (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
DK97305585T 1996-08-01 1997-07-25 Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse DK0821955T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2290096P 1996-08-01 1996-08-01

Publications (1)

Publication Number Publication Date
DK0821955T3 true DK0821955T3 (da) 2002-03-18

Family

ID=21812011

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97305585T DK0821955T3 (da) 1996-08-01 1997-07-25 Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse

Country Status (19)

Country Link
EP (1) EP0821955B1 (da)
JP (1) JP2000515547A (da)
KR (1) KR20000029647A (da)
CN (1) CN1226165A (da)
AT (1) ATE213413T1 (da)
AU (1) AU716972B2 (da)
BR (1) BR9710901A (da)
CA (1) CA2261802C (da)
CZ (1) CZ27299A3 (da)
DE (1) DE69710526T2 (da)
DK (1) DK0821955T3 (da)
EA (1) EA199900174A1 (da)
ES (1) ES2171838T3 (da)
HU (1) HUP9904578A2 (da)
IL (1) IL128280A0 (da)
NO (1) NO990436L (da)
PL (1) PL331407A1 (da)
PT (1) PT821955E (da)
WO (1) WO1998005324A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
PT3061821T (pt) * 2009-07-22 2019-09-05 PureTech Health LLC Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
KR102408292B1 (ko) 2018-09-28 2022-06-10 카루나 세러퓨틱스 인코포레이티드 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법
CN111430027B (zh) * 2020-03-18 2023-04-28 浙江大学 基于肠道微生物的双相情感障碍生物标志物及其筛选应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
FI960747A7 (fi) * 1993-08-19 1996-04-17 Novo Nordisk As Antipsykoottinen menetelmä
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
JPH10508028A (ja) * 1994-10-31 1998-08-04 イーライ・リリー・アンド・カンパニー 不安を治療する方法

Also Published As

Publication number Publication date
PT821955E (pt) 2002-07-31
EP0821955A3 (en) 1998-04-22
DE69710526D1 (de) 2002-03-28
NO990436D0 (no) 1999-01-29
EP0821955A2 (en) 1998-02-04
ATE213413T1 (de) 2002-03-15
BR9710901A (pt) 1999-08-17
DE69710526T2 (de) 2002-10-02
JP2000515547A (ja) 2000-11-21
AU4046897A (en) 1998-02-25
WO1998005324A1 (en) 1998-02-12
CZ27299A3 (cs) 1999-08-11
IL128280A0 (en) 1999-11-30
AU716972B2 (en) 2000-03-09
HUP9904578A2 (hu) 2000-06-28
ES2171838T3 (es) 2002-09-16
CN1226165A (zh) 1999-08-18
EA199900174A1 (ru) 1999-08-26
CA2261802A1 (en) 1998-02-12
KR20000029647A (ko) 2000-05-25
PL331407A1 (en) 1999-07-19
EP0821955B1 (en) 2002-02-20
CA2261802C (en) 2006-11-07
NO990436L (no) 1999-01-29

Similar Documents

Publication Publication Date Title
ES2188095T3 (es) Carboxamidas heterociclicas.
FI935529A0 (fi) Aminometylensubstituerade icke-aromatiska heterocykliska foereningar
DK0553307T3 (da) Herbicide substituerede arylhalogenalkylpyrazoler
DK0627221T3 (da) Substans P antagonister til behandling af emesis
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
ATE253063T1 (de) 5-ht1f-agonisten
DE69901717D1 (de) Phosphohalohydrine, verfahren zu deren herstellung und verwendungen
NO20014925L (no) Farmasöytiske forbindelser
ES2132284T3 (es) Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DK0952154T3 (da) N-acyl- og N-aroylaralkylamider
DK0796618T3 (da) Behandling og profylakse af pankreatitis
DK0821955T3 (da) Anvendelse af 3-(4-heoxyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridin (xanomelin) til behandling af bipolar lidelse
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
DK0480155T3 (da) 4-Substituerede dihydropyrido(4,3-d)pyrimidiner som analgetica og topiske antiinflammatoriske midler til behandling af hudlidelser
DK0656209T3 (da) Melatoninderivater til anvendelse ved behandling af desynkroniseringsforstyrrelser
IL149280A0 (en) Methods, kits and compositions for using pyrrole derivatives
EP0821957A3 (en) Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
BR9902096A (pt) Pitazóis.
MX9703363A (es) Nuevos derivados de pirimidiniloxi- y pirimidinilamino etilfenil-dioxolano.
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ES2141830T3 (es) Derivado de diester fosfonico.
PT97762A (pt) Processo para a preparacao de pirido {3,4-b} pirrolo-{1,2-e} {1,4,5} oxadiazepinas e de analogos relacionados e de composicoes farmaeuticas que os contem
DK0810223T3 (da) Adamantylsubstituerede oxindoler som farmaceutiske midler
DK1304107T3 (da) Anvendelse af oxozolidinonderivater til behandling af psoriasis